A detailed history of Frontier Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Frontier Wealth Management LLC holds 6,092 shares of LLY stock, worth $4.85 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,092
Previous 6,092 -0.0%
Holding current value
$4.85 Million
Previous $1.88 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $36,513 - $42,872
131 Added 2.15%
6,223 $2.02 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $151,375 - $188,120
645 Added 11.84%
6,092 $1.88 Million
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $164,140 - $203,699
730 Added 15.48%
5,447 $1.51 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $124,096 - $152,717
-560 Reduced 10.61%
4,717 $1.09 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $10,833 - $14,012
60 Added 1.15%
5,277 $1.21 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $45,680 - $59,136
278 Added 5.63%
5,217 $975,000
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $17,612 - $23,305
-135 Reduced 2.66%
4,939 $834,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $1,462 - $1,691
-10 Reduced 0.2%
5,074 $751,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $101,905 - $122,642
747 Added 17.22%
5,084 $835,000
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $99,644 - $123,331
837 Added 23.91%
4,337 $602,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $39,453 - $48,866
-369 Reduced 9.54%
3,500 $460,000
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $32,464 - $35,312
-304 Reduced 7.28%
3,869 $433,000
Q2 2019

Aug 16, 2019

BUY
$110.79 - $129.32 $19,609 - $22,889
177 Added 4.43%
4,173 $462,000
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $9,127 - $10,743
82 Added 2.1%
3,996 $519,000
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $7,518 - $8,423
-71 Reduced 1.78%
3,914 $453,000
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $5,323 - $6,653
62 Added 1.58%
3,985 $428,000
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $5,450 - $6,255
-72 Reduced 1.8%
3,923 $335,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $561,769 - $663,132
-7,570 Reduced 65.46%
3,995 $309,000
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $466,976 - $500,885
-5,699 Reduced 33.01%
11,565 $977,000
Q3 2017

Nov 13, 2017

SELL
$77.07 - $85.54 $32,292 - $35,841
-419 Reduced 2.37%
17,264 $1.48 Million
Q2 2017

Aug 14, 2017

BUY
N/A
17,683
17,683 $1.46 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.